Search clinical trials for: 12 months of P2Y12 receptor antagonist

Total 9505 results

University of Oxford
Oxford University Hospitals NHS Trust

Unknown

The Oxford Marfan Trial

Marfan Syndrome

United Kingdom
Yonsei University
Yuhan Corporation; OrbusNeich

Terminated

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy (INNOVATION)

Stable Angina

Korea, Republic of
Bader, Ted, M.D.

Completed

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

Chronic Hepatitis C

United States
Science Valley Research Institute
Wyeth is now a wholly owned subsidiary of Pfizer

Recruiting

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. (AGRIPPA)

Critical Limb Ischemia

Brazil
Medical University of Vienna

Unknown

Add-on Cangrelor in STEMI-triggered Cardiac Arrest

Cardiopulmonary Arrest With Successful Resuscitation | ACS - Acute Coronary Syndrome | Hypothermia, Induced

Austria
Samsung Medical Center

Unknown

Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES (SMART-CHOICE)

Coronary Artery Disease

Korea, Republic of
Assistance Publique Hopitaux De Marseille

Completed

Simulation-based Education for Managing Stress in ICU Nurses (SISTRESSREA)

Professional Stress

France
Gangnam Severance Hospital

Active, not recruiting

Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent

Coronary Artery Disease

Korea, Republic of
Ajou University School of Medicine
B. Braun Korea Co., Ltd.

Unknown

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Korea, Republic of
The George Institute

Not yet recruiting

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

Chronic Kidney Diseases
Mundipharma Research Limited

Completed

A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.

Pain

United Kingdom
Centre Francois Baclesse
National Cancer Institute, France; ARC Foundation for Cancer Research

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal

France
Amsterdam UMC, location VUmc

Completed

Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes (LIBRA)

Obesity | Type 2 Diabetes

Netherlands
Actelion

Withdrawn

Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension (LONGACT)

Pulmonary Arterial Hypertension
Indiana University

Recruiting

Does Oxytocin Alter Tolerance to or Motivation for Alcohol

Alcohol Use Disorder

United States
The Netherlands Cancer Institute
AstraZeneca

Suspended

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Breast Cancer

Netherlands
Shalvata Mental Health Center

Not yet recruiting

The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders

Eating Disorders

Israel
Centre Hospitalier Universitaire de Nīmes

Completed

Low Energy Shockwave Therapy for Improving Erectile Dysfunction (Shock-ED)

Erectile Dysfunction

France
Gangnam Severance Hospital

Completed

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (OPTIMA-C)

Ischemic Heart Disease
Clinical Hospital Centre Zagreb
Croatian Science Foundation; University of Zagreb School of Medicine

Recruiting

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

Drug-Related Side Effects and Adverse Reactions | Pharmacogenetics | Cardiovascular Drugs

Croatia
Marissa Jarosinski

Recruiting

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Peripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery Disease

United States
University of Kansas Medical Center
National Cancer Institute (NCI)

Recruiting

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Breast Cancer | Risk Reduction

United States
Biogen

Terminated

Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency (POSEIDON)

Heart Failure | Renal Insufficiency

United States
Second Affiliated Hospital, School of Medicine,...

Unknown

DUAL Antithrombotic Therapy in Patients With AF and ACS

Atrial Fibrillation | Acute Coronary Syndromes
Organon and Co

Terminated

An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

Hypertension
Aristotle University Of Thessaloniki
Alcon Research

Completed

Value of an Intervention to Enhance Adherence in Glaucoma Patients

Glaucoma
Washington University School of Medicine
Varian Medical Systems

Completed

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small-Cell-Lung

United States
Yonsei University

Terminated

Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)

Peripheral Artery Disease With Intermittent Claudication

Korea, Republic of
Suzhou Kintor Pharmaceutical Inc,

Completed

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Takeshi Morimoto

Completed

Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (ONCO DVT)

Neoplasms | Venous Thrombosis | Anticoagulant

Japan
Suzhou Kintor Pharmaceutical Inc,

Completed

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Gruppo di Ricerca GISSI

Completed

GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

Atrial Fibrillation

Italy, Switzerland
Ottawa Hospital Research Institute

Unknown

The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers (OTT 17-01)

Breast Cancer
Yonsei University

Completed

Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery

Coronary Artery

Korea, Republic of
Dong-A University

Unknown

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI (BULK-STEMI)

ST Elevation Myocardial Infarction

Korea, Republic of
Otsuka Canada Pharmaceutical Inc.
Lundbeck Canada Inc.

Recruiting

Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) (INITIATE)

Schizophrenia | Schizo Affective Disorder | Bipolar I Disorder

Canada
Pamukkale University

Completed

Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide

Nausea | Akathisia
AstraZeneca

Completed

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Healthy

United States
Tracon Pharmaceuticals Inc.
Janssen Pharmaceutica N.V., Belgium

Completed

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Metastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, Prostate

United States
Northwestern University
National Cancer Institute (NCI)

Recruiting

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Cancer Survivor | Invasive Breast Carcinoma | Ductal Breast Carcinoma In Situ

United States
Fu Wai Hospital, Beijing, China

Not yet recruiting

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

In-stent Restenosis

China
Erasmus Medical Center

Active, not recruiting

The Effect of Early Glasses on the Development of Amblyopia (EGS)

Refractive Errors | Amblyopia

Netherlands
Bristol-Myers Squibb

Completed

A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer

Prostate Cancer

United States
Medical College of Wisconsin

Active, not recruiting

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Breast Cancer | Invasive Breast Cancer

United States
Institut Claudius Regaud
PHARMACIA SAS

Completed

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant (TAMARO)

Breast Neoplasms

France
Janssen-Cilag International NV

Completed

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

Schizophrenia

Germany, Spain, Belgium, Hungary, France, Italy, United Kingdom
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Schizophrenia

Japan
EMS

Recruiting

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

Asthma

Brazil
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly in Patients With Schizophrenia

Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation

Schizophrenia

France, Germany, Spain, Israel, Malaysia, Turkey, Taiwan, Greece, Korea, Republic of, Russian Federation, Netherlands, United Kingdom, Croatia, Denmark, Saudi Arabia

3

Subscribe